MUSTANG BIO INC (MBIO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.54-3.05%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MBIO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||||||
| R&D Expenses | — | — | — | — | — | — | — | — | 2.1 | 0.1 | 2.0 |
| Operating Income | (3.5) | (2.4) | (16.2) | (49.3) | (76.2) | (66.7) | (56.8) | (45.9) | (31.2) | (31.8) | (11.4) |
| Earnings from Continuing Operations | |||||||||||
| Other Non-Operating Income / Expenses | 0.5 | 0.5 | 0.5 | (2.3) | (1.4) | 0.4 | (3.2) | (0.5) | 0.6 | 0.5 | (1.3) |
| Asset Writedown | — | — | 3.7 | 0.0 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (1.9) | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | 0.0 | — | — | — | — | — | — | — | — | — |
| Net Income | |||||||||||
| Net Income | (3.0) | (1.9) | (15.8) | (51.6) | (77.5) | (66.4) | (60.0) | (46.4) | (30.7) | (31.3) | (12.7) |
| Per Share | |||||||||||
| Basic EPS | (0.45) | (0.39) | (38.57) | (299.95) | (10.09) | (0.76) | — | — | — | — | — |
| Diluted EPS | (0.45) | (0.39) | (38.57) | (299.95) | (10.09) | (0.76) | — | — | — | — | — |
| Basic Weighted Avg Shares | 6.7 | 4.9 | 0.6 | 0.2 | 7.7 | 87.9 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 6.7 | 4.9 | 0.6 | 0.2 | 7.7 | 87.9 | — | — | — | — | — |
| Supplemental | |||||||||||
| EBIT | (3.5) | (2.4) | (16.2) | (49.3) | (76.2) | (66.7) | (56.8) | (45.9) | (31.2) | (31.8) | (11.4) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.